Percutaneous Implantation of Autologous Bone Marrow Osteoprogenitor Cells as Treatment of Bone Avascular Necrosis Related to Sickle Cell Disease
Open Access
- 25 April 2008
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Orthopaedics Journal
- Vol. 2 (1) , 62-65
Abstract
The treatment of bone a vascular necrosis is a big challenge considering the youthfulness of the patients involved by necrosis in sickle cell disease and the importance of the generated disability. A vascular osteonecrosis is an epiphysis pathology which could be treated by joint replacement with success, however, multiple surgical procedures are mostly necessary during the patient’s life with a hazardous long term functional results. The treatment by autologous bone marrow grafting is an effective alternative which preserve the native joint. Using this mini-invasive high technology surgical treatment in early stages, a joint replacement could be avoided in many patients.Keywords
This publication has 25 references indexed in Scilit:
- Bone involvement in sickle cell diseaseBritish Journal of Haematology, 2005
- ENGINEERING PRINCIPLES OF CLINICAL CELL-BASED TISSUE ENGINEERINGJournal of Bone and Joint Surgery, 2004
- THE NATURAL HISTORY OF SYMPTOMATIC OSTEONECROSIS IN ADULTS WITH SICKLE-CELL DISEASEJournal of Bone and Joint Surgery, 2003
- Treatment of Osteonecrosis With Autologous Bone Marrow GraftingClinical Orthopaedics and Related Research, 2002
- The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral headThe Journal of Bone and Joint Surgery. British volume, 2001
- Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosisThe Journal of Bone and Joint Surgery. British volume, 1999
- Mesenchymal Stem Cells in Osteobiology and Applied Bone RegenerationClinical Orthopaedics and Related Research, 1998
- Sickle Cell Disease as a Cause of Osteonecrosis of the Femoral HeadNew England Journal of Medicine, 1991
- Orthopaedic manifestations of sickle-cell disease.1990
- Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy.Journal of Bone and Joint Surgery, 1988